ITCMDBv1
DiseaseID 4110

移植物抗宿主病

disease

NCI2016_NICHD_1602D:A reaction, which may be fatal, in an immunocompromised subject (host) who has received an antigenically incompatible tissue transplant (graft) from an immunocompetent donor. The reaction is secondary

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Disease: 1Symptom: 12Target: 12Links: 24
Arranging relationship network...

Record Fields

Scalar fields from the final disease record.

Disease Id
4110
Core Entity Id
60407
Source Entity Count
1
Preferred Name
Graft-Vs-Host Disease
Name Cn
移植物抗宿主病
Name Pinyin
Yi Zhi Wu Kang Su Zhu Bing
Name En
Graft-Vs-Host Disease
Name Latin
Bilingual Status
complete
Disease Type
disease
Umls Disease Type
Disease or Syndrome
Disgenet Type
disease
Mesh Class
Immune System Diseases
Do Class
Hpo Class
Mesh Class Name
Immune System Diseases
Hpo Class Name
Do Class Name
Disease Definition
NCI2016_NICHD_1602D:A reaction, which may be fatal, in an immunocompromised subject (host) who has received an antigenically incompatible tissue transplant (graft) from an immunocompetent donor. The reaction is secondary to the activation of the transplanted cells against those host tissues that express an antigen not expressed by the donor, and is seen most commonly following bone marrow transplantation; acute disease is seen after 5-40 days, and chronic disease occurs weeks to months after transplantation.|NCI2016_NCI-GLOSS_1602D:A disease caused when cells from a donated stem cell graft attack the normal tissue of the transplant patient. Symptoms include jaundice, skin rash or blisters, a dry mouth, or dry eyes.|NCI2016_02D:A reaction, which may be fatal, in an immunocompromised subject (host) who has received an antigenically incompatible tissue transplant (graft) from an immunocompetent donor. The reaction is secondary to the activation of the transplanted cells against those host tissues that express an antigen not expressed by the donor, and is seen most commonly following bone marrow transplantation; acute disease is seen after 5-40 days, and chronic disease occurs weeks to months after transplantation.|MSH2017_2016_08_12:The clinical entity characterized by anorexia, diarrhea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the GRAFT VS HOST REACTION.|CSP2006:caused by immunologically competent T cells in the graft recognizing and attacking host tissues as foreign; clinical symptoms include skin rashes, diarrhea, and abnormal liver functions.
Version
v2
Suppressed
No

Names

Preferred names, aliases, and source labels retained in the final schema.

Name
Graft-Vs-Host Disease
Role
preferred
Name
Graft Vs Host Disease
Role
alias

Cross References

Trusted external identifiers retained for this final record.

Herb
HBDIS001214
Me Sh
D006086
Umls
C0018133
Icd10
D89.81D89.813
Sym Map
SMDE09127
Dis Ge Net
C0018133
Umls Sty
T047
Me Sh Class
C20
Tcmbank Disease
27040

Attributes

Merged source attributes and domain-specific metadata.

Version
v2
Suppress
0
Disease Type
disease
Umls Disease Type
Disease or Syndrome
Disease Definition
NCI2016_NICHD_1602D:A reaction, which may be fatal, in an immunocompromised subject (host) who has received an antigenically incompatible tissue transplant (graft) from an immunocompetent donor. The reaction is secondary to the activation of the transplanted cells against those host tissues that express an antigen not expressed by the donor, and is seen most commonly following bone marrow transplantation; acute disease is seen after 5-40 days, and chronic disease occurs weeks to months after transplantation.|NCI2016_NCI-GLOSS_1602D:A disease caused when cells from a donated stem cell graft attack the normal tissue of the transplant patient. Symptoms include jaundice, skin rash or blisters, a dry mouth, or dry eyes.|NCI2016_02D:A reaction, which may be fatal, in an immunocompromised subject (host) who has received an antigenically incompatible tissue transplant (graft) from an immunocompetent donor. The reaction is secondary to the activation of the transplanted cells against those host tissues that express an antigen not expressed by the donor, and is seen most commonly following bone marrow transplantation; acute disease is seen after 5-40 days, and chronic disease occurs weeks to months after transplantation.|MSH2017_2016_08_12:The clinical entity characterized by anorexia, diarrhea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the GRAFT VS HOST REACTION.|CSP2006:caused by immunologically competent T cells in the graft recognizing and attacking host tissues as foreign; clinical symptoms include skin rashes, diarrhea, and abnormal liver functions.
Me Sh Disease Class
Immune System Diseases
Dis Ge Net Disease Type
disease
Disease Class Name Me Sh
Immune System Diseases
Umls Semantic Type Name
Disease or Syndrome